Abstract
Decisions on health spending depend ultimately on the valuation of human life in the country concerned. Previous attempts in the UK have been linked to the onesize-fits-all “value of a prevented fatality” (VPF), now shown to be based on a fundamentally flawed method. An objective and validated alternative is available in the J-value (J for “judgment”), which addresses the improved life expectancy a treatment offers. The J-value sheds important light on what Man chooses to spend on life-extending measures, allowing lessons to be drawn for the desirable relationship between GDP and spending on health.
| Original language | English |
|---|---|
| Pages (from-to) | 17 – 30 |
| Number of pages | 14 |
| Journal | Nanotechnology Perceptions |
| Volume | 13 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 28 Mar 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- economics
- GDP
- HEALTH
- j-vALUE
- life expectanc
- life quality index
Fingerprint
Dive into the research topics of 'Does health spending need to outpace GDP per head?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver